Expression of INK4 inhibitors of cyclin D-dependent kinases during mouse brain development

Cell Growth and Differentiation

Volumn 8, Issue 11, 1997, Pages 1139-1150

  Zindy, Frederique ^a   Soares, Holly ^a   Herzog, Karl Heinz ^a   Morgan, James ^a   Sherr, Charles J ^a   Roussel, Martine F ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; CELL DIFFERENTIATION; CELL DIVISION; EMBRYO; ENZYME INHIBITION; MITOSIS; MOUSE; NEUROEPITHELIOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SPINAL GANGLION;

ANIMALS; BRAIN; CARRIER PROTEINS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P18; CYCLIN-DEPENDENT KINASE INHIBITOR P19; CYCLIN-DEPENDENT KINASES; DENTATE GYRUS; ENZYME INHIBITORS; EXCITATORY AMINO ACID AGONISTS; KAINIC ACID; MICE; NEOCORTEX; PROTO-ONCOGENE PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 0030784943     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (88)

1. 1 cyclins. Cell, 73: 1059-1065, 1993.
2. 1 phase progression: cycling on cue. Cell, 79: 551-555, 1994.
3. Nevins, J. R. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science (Washington DC), 258: 424-429, 1992.
4. La Thangue, N. B. DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell cycle control. Trends Biochem. Sci., 19: 108-114, 1994.
5. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell, 81: 323-330, 1995.
6. 1 control in retinoblastoma gene-deficient cells, independent of CDK4 activity. Mol. Cell. Biol., 15: 2600-2611, 1995.
7. Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J., Strauss, M., Peters, G. and Bartek, J. Retinoblastoma protein-dependent cell cycle inhibition by the tumor suppressor p16. Nature (Lond.), 375: 503-506, 1995.
8. Koh, J., Enders, G. H., Dynlacht, B. D., and Harlow, E. Tumour-derived p16 alleles encoding proteins defective in cell cycle inhibition. Nature (Lond.), 375: 506-510, 1995.
9. ink4 requires functional retinoblastoma protein. Proc. Natl. Acad. Sci. USA, 92: 6289-6293, 1995.
10. Morgan, D. O. Principles of cdk regulation. Nature (Lond.), 374: 131-134, 1995.
11. Elledge, S. J., and Harper, J. W. CDK inhibitors: on the threshold of check points and development. Curr. Opin. Cell Biol., 6: 847-852, 1994.
12. 1 cyclin-dependent kinases. Genes Dev., 9: 1149-1163, 1995.
13. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
14. 1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
15. Gu, Y., Turek, C. W., and Morgan, D. O. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature (Lond.), 366: 707-710, 1993.
16. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature (Lond.), 366: 701-704, 1993.
17. Kip1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev., 8: 9-22, 1994.
18. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78: 59-66, 1994.
19. 1 cyclin/cdk protein kinase activity, is related to p21. Cell, 78: 67-74, 1994.
20. Kip2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev., 9: 639-649, 1995.
21. CIP1 cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev., 9: 650-662, 1995.
22. 1 arrest and apoptosis. Cancer Res., 54: 1169-1174, 1994.
23. 1 arrest. Cell, 76: 1013-1023, 1994.
24. Brugarolas, J., Chandrasekaran, C., Gordon, J. I., Beach, D., Jacks, T., and Hannon, G. J. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature (Lond.), 377: 552-557, 1995.
25. 1 checkpoint control. Cell, 82: 675-684, 1995.
26. 1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase-4 activation. Cell, 79: 487-496, 1994.
27. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature (Lond.), 372: 570-573, 1994.
28. Reynisdóttir, I., Polyak, K., Iavarone, A., and Massagué, J. Kip/Cip and Ink4 cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev., 9: 1831-1845, 1995.
29. Kip1 for restriction point control of the fibroblast cell cycle. Science (Washington DC), 272: 877-880, 1996.
30. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell, 85: 707-720, 1996.
31. Kip1. Cell, 85: 721-732, 1996.
32. Kip1-deficient mice. Cell, 85: 733-744, 1996.
33. KIP2 indicates a role in Beckwith-Widemann syndrome. Nature (Lond.), 387: 151-158, 1997.
34. Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev., 11: 973-983, 1997.
35. Serrano, M., Hannon, G. J., and Beach, D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/cdk4. Nature (Lond.), 366: 704-707, 1993.
36. INK4b is a potential effector of cell cycle arrest mediated by TGF-β. Nature (Lond.), 371: 257-261, 1994.
37. INK4/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev., 8: 2939-2952, 1994.
38. Hirai, H., Roussel, M. F., Kato, J., Ashmun, R. A., and Sherr, C. J. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol., 15: 2672-2681, 1995.
39. INK4. Mol. Cell. Biol., 15: 2682-2688, 1995.
40. INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene, 15: 203-211, 1997.
41. Serrano, M., Lee, H-W., Chin, L., Cordon-Cardo, C., Beach, D., and DePinho, R. A. Role of the INK4a locus in tumor suppression and cell mortality. Cell, 85: 27-37, 1996.
42. CDKN2 expression and its implications for cell immortalization and senescence. Mol. Cell. Biol., 16: 859-867, 1996.
43. Pollock, P. M., Pearson, J. V., and Hayward, N. K. Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions. Genes Chromosomes Cancer, 15: 77-88, 1996.
44. Hall, M., and Peters, G. Genetic alterations of cyclins, cyclin-dependent kinases, and cdk inhibitors in human cancer. Adv. Cancer Res., 68: 67-108, 1996.
45. Sherr, C. J. Cancer cell cycles. Science (Washington DC), 274: 1672-1677, 1996.
46. Ink4c and its predominant association with CDK4 and CDK6 during myogenic differentiation. Mol. Biol. Cell, 7: 1587-1599, 1996.
47. INK4c and IL-6. Immunity, 6: 47-56, 1997.
48. INK4d, a specific inhibitor of cyclin D-dependent kinases. Blood, 90: 126-137, 1997.
49. Jacobson, M. The germinal cells, histogenesis, and lineages of nerve cells. In: Developmental Neurobiology, Ed. 3, pp. 41-89. New York: Plenum Press, 1991.
50. Chenn, A., and McConnell, S. K. Cleavage orientation and the asymmetric inheritance of Notch1 immunoreactivity in mammalian neurogenesis. Cell, 82: 631-642, 1995.
51. McConnell, S. K. Strategies for the generation of neuronal diversity in the developing central nervous system. J. Neurosci., 75: 6987-6998, 1995.
52. Caviness, V. W., Jr., Takahashi, T., Nowakowski, R. S., and Tsai, L. Regulated and nonregulated parameters of neocortical cytogenesis. In: B. Albowitz, K. Albus, U. Kuhnt, H. C. Northdurft, and P. Wahle, (eds.) Structural and Functional Organization of the Neocortex, Berling, pp. 8-22. Heidelberg: Springer-Verlag, 1994.
53. Takahashi, T., Nowakowshi, R. S., and Caviness, V. S. The cell cycle of the pseudostratified venticular epithelium of the embryonic murine cerebral wall. J. Neurosci., 15: 6046-6057, 1995.
54. Caviness, V. S., Jr., Takahashi, T., and Nowakowski, R. S. Numbers, time and neocortical neuronogenesis: a general developmental and evolutionary model. Trends Neurosci., 18: 379-383, 1995.
55. Kip1 in neurons. Proc. Natl. Acad. Sci. USA, 93: 3259-3263, 1996.
56. Ben-Ari, Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience, 14: 375-403, 1995.
57. Kasof, G. M., Mandelzys, A., Maika, S. D., Hammer, R. E., Curran, T., and Morgan, J. I. Kainic acid-induced neuronal death is associated with DNA damage and a unique immediate-early gene response in c-fos-lacZ transgenic rats. J. Neurosci., 15: 4238-4249, 1995.
58. INK4/MTS1 tumor suppressor gene product. EMBO J., 14: 503-511, 1995.
59. Kip1 coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev., 11: 492-503, 1997.
60. Freeman, R. S., and Johnson, E. M. J. Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of cyclin D1 during programmed cell death. Neuron, 12: 343-355, 1994.
61. Kranenburg, O., van der Eb, A. J., and Zantema, A. Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J., 15: 46-54, 1996.
62. CIP1 in muscle and other terminally differentiating cells. Science (Washington DC), 267: 1024-1027, 1995.
63. Hayes, T. E., Valtz, N. L. M., and McKay, R. D. G. Downregulation of CDC2 upon terminal differentiation of neurons. New Biol., 3: 259-269, 1991.
64. Tsai, L-H., Takahashi, T., Caviness, V. S., Jr., and Harlow, E. Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development (Camb.), 119: 1029-1040, 1993.
65. Lew, J., Beaudette, K., Litwin, C. M. E., and Wang, J. H. Purification and characterization of a novel proline-directed protein kinase from bovine brain. J. Biol. Chem., 267: 13383-13390, 1992.
66. Shetty, K. T., Link, W. T., and Pant, H. C. Cdc2-like kinase from rat spinal cord specifically phosphorylates KSPXX motifs in neurofilament proteins: isolation and characterization. Proc. Natl. Acad. Sci. USA, 90: 6844-6848, 1993.
67. Tsai, L-H., Delalle, I., Caviness, V. S., Chae, T., and Harlow, E. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature (Lond.), 371: 419-423, 1994.
68. Lew, J., Huang, Q. Q., Winkfein, R. J., Qi, Z., Aebersold, R., Hunt, T., and Wang, J. H. Neuronal cdc2-like kinase is a complex of cyclin-dependent kinase 5 and a novel brain-specific regulatory subunit. Nature (Lond.), 371: 423-425, 1994.
69. Ishiguro, K., Kobayashi, S., Omori, A., Takamatsu, M., Yonekura, S., Anzai, K., Imahori, K., and Uchida, T. Identification of the 23 kDa subunit of tau protein kinase II as a putative activator of cdk5 in bovine brain. FEBS Lett., 342: 203-208, 1994.
70. Ohshima, T., Ward, J. M., Huh, C. G., Longnecker, G., Veerana, K., Pant, H. C., Brady, R. O., Martin, L. J., and Kulkami, A. B. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology, and perinatal death. Proc. Natl. Acad. Sci. USA, 93: 11173-11178, 1996.
71. Chae, T., Kwon, Y. T., Bronson, R., Dikkes, P., Li, E., and Tsai, L-H. Mice lacking p35, a neuronal specific activator of cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron, 18: 29-42, 1997.
72. Feddersen, R. M., Ehlenfelt, R., Yunis, W. S., Clark, H. B., and Orr, H. T. Disrupted cerebellar cortical development and progressive degen-eration of Purkinje cells in SV40 T antigen transgenic mice. Neuron, 9: 955-966, 1992.
73. Clarke, A. R., Maandag, E. R., van Roon, M., van der Lugt, N. M. T., van der Valk, M., Hooper, M. L., Berns, A., and te Riele, H. Requirement for a functional Rb-1 gene in murine development. Nature (Lond.), 359: 328-330, 1992.
74. Jacks, T., Faxeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., and Weinberg, R. A. Effects of an Rb mutation in the mouse. Nature (Lond.), 359: 295-300, 1992.
75. Lee, E. Y. P., Chang, C., Hu, N., Wang, Y. J., Lai, C., Herrup, K., Lee, W., and Bradley, A. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature (Lond.), 359: 288-294, 1992.
76. Lee, E-Y-H. P., Hu, N., Yuan, S-S. F., Cox, L. A., Bradley, A., Lee, W-H., and Herrup, K. Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes Dev., 8: 2008-2021, 1994.
77. Morgan, J. I., and Curran, T. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu. Rev. Neurosci., 14: 421-451, 1991.
78. Lason, W., and Przewlocki, R. Seizure-induced expression of G proteins in the rat hippocampus. Brain Res. Mol. Brain Res., 24: 65-69, 1994.
79. Tsaur, M. L., Sheng, M., Lowenstein, D. H., Jan, Y. N., and Jan, L. Y. Differential expression of K+ channel mRNAs in the rat brain and down-regulation in the hippocampus following seizures. Neuron, 8: 1055-1067, 1992.
80. Rocamora, N., Massieu, L., Boddeke, H. W., Palacios, J. M., and Mengod, G. Differential regulation of the expression of nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 mRNAs in adult rat brain after intrahippocampal injection of quinoline acid. Brain Res. Mol. Brain Res., 26: 89-98, 1994.
81. Elmer, E., Kokaia, M., Kokaia, Z., Ferencz, I., and Lindvall, O. Delayed kindling development after rapidly recurring seizures: relation to mossy fiber sprouting and neurotrophin, GAP-43 and dynorphin gene expression. Brain Res., 712: 19-34, 1996.
82. Vick, R. S., Rafiq, A., Coulter, D. A., Jakoi, E. R., and Delorenzo, R. J. GABAA α 2 mRNA levels are decreased following induction of spontaneous epileptiform discharges in hippocampal-entorhinal cortical slices. Brain Res., 721: 111-119, 1996.
83. INK4b genes. Oncogene, 11: 635-645, 1995.
84. Cox, K. H., DeLeon, D. V., Angerer, L. M., and Angerer, R. C. Detection of mRNAs in sea urchin embroys by in situ hybridization using asymmetric RNA probes. Dev. Biol., 101: 485-502, 1984.
85. Simmons, D. M., Arriza, J. L., and Swanson, L. W. A complete protocol for in situ hybridization of messenger RNAs in brain and other tissues with radio-labeled single-stranded RNA probes. J. Histotechnol. 12: 169-181, 1989.
86. Lugo, D. I., Roberts, J. L., and Pintar, J. E. Analysis of proopiomelanocortin gene expression during prenatal development of the rat pituitary gland. Mol. Endocrinology, 3: 1313-1324, 1989.
87. Downing, J. R., Rettenmier, C. W., and Sherr, C. J. Ligand-induced tyrosine kinase activity of the colony stimulating factor-1 receptor in a murine macrophage cell line. Mol. Cell. Biol., 8: 1795-1799, 1988.
88. Matsushime, H., Quelle, D. E., Shurtleff, S. A., Shibuya, M., Sherr, C. J., and Kato, J. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol., 14: 2066-2076, 1994.